Ticker LaunchSPAC · Liquidated
Orion Biotech Opportunities Corp.
Orion Biotech Opportunities Corp. is a blank-check company (SPAC) that raised $200M in its initial public offering on May 14, 2021, listing on Nasdaq Capital Market. It did not complete a business combination and liquidated around May 17, 2023, returning the trust to public shareholders. TCL led the IPO, with Committed Capital. Kirkland & Ellis advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.
- Status
- Liquidated
- IPO date
- May 14, 2021
- IPO size
- $200M
- IPO exchange
- Nasdaq Capital Market
- IPO underwriters
- TCL and Committed Capital
- SPAC counsel (IPO)
- Kirkland & Ellis and Maples and Calder
- Underwriters' counsel (IPO)
- Ellenoff Grossman & Schole
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) May 14, 2021
- All filings on EDGAR CIK 1847416
Other SPAC IPOs from 2021
- Angel Pond Holdings CorpMay 19, 2021 · $250M
- Osiris Acquisition Corp.May 17, 2021 · $230M
- Artisan Acquisition Corp.May 17, 2021 · $300M
- Quinpario Acquisition Corp. 2May 12, 2021
- B. Riley Principal 250 Merger Corp.May 10, 2021 · $150M
- Data Knights Acquisition Corp.May 10, 2021 · $100M